Usual Dosing (Adults) |
||
<50 kg: 100 mg q6h or 200 mg q12h (controlled release)
>50 kg: 150 mg q6h or 300 mg q12h (controlled release); if no response, may increase to 200 mg q6h; maximum dose required for patients with severe refractory ventricular tachycardia is 400 mg q6h. |
||
Renal Dosing |
||
|
||
Hemodialysis |
||
|
||
Reference(s) |
||
National Institutes of Health, U.S. National Library of Medicine, DailyMed Database. Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates. A local search option of this data can be found here. |
||